Description

The reference listed drugs selected by China National Medical Products Administration (NMPA) are reference products to which generic drugs should be equivalent in quality and therapeutic efficacy.

Related resource: Generic Drug Registration Application (ANDA) in China

6773 results
Export
Log in to view more data,
No. Drug Name Dosage Form Brand Name Strength MAH Note 1 Note 2 Batch
90-1 / Alimera Sciences, Inc. Original drug imported to China Original drug imported to China The 90th Batch of Reference Listed Drugs
90-2 旁必福 Amgen Europe B.V. Original drug imported to China Original drug imported to China The 90th Batch of Reference Listed Drugs
90-3 旁必福 Amgen Europe B.V. Original drug imported to China Original drug imported to China The 90th Batch of Reference Listed Drugs
90-4 旁必福 Amgen Europe B.V. Original drug imported to China Original drug imported to China The 90th Batch of Reference Listed Drugs
90-5 Ryzumvi FAMYGEN LIFE SCIENCES INC Original drug not imported to China US Orange Book The 90th Batch of Reference Listed Drugs
90-6 Entresto Novartis Pharmaceuticals Corporation Original drug not imported to China US Orange Book The 90th Batch of Reference Listed Drugs
90-7 Entresto Novartis Pharmaceuticals Corporation Original drug not imported to China US Orange Book The 90th Batch of Reference Listed Drugs
90-8 Qbrelis AZURITY PHARMACEUTICALS INC Original drug not imported to China US Orange Book The 90th Batch of Reference Listed Drugs
90-9 / HIKMA PHARMACEUTICALS USA INC Original drug not imported to China US Orange Book The 90th Batch of Reference Listed Drugs
90-10 / BRAINTREE LABORATORIES INC Original drug not imported to China US Orange Book The 90th Batch of Reference Listed Drugs